QA: Rezolute Inc in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001509261_2022_Rezolute_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001509261, Rezolute Inc

  xvar xval
0 AssetsCurrent 41,993,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 29,000
3 remainder_Assets 587,000
4 LiabilitiesCurrent 1,968,000
5 LiabilitiesNoncurrent 187,000
6 remainder_Liabilities 14,355,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 8,078,357
9 ResearchAndDevelopmentExpense 15,431,355
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 1,683,941
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 42,609,000
1 Liabilities 16,510,000
2 Expenses 23,509,712
3 Revenues 0
4 StockholdersEquity 26,099,000
5 NetIncome -21,825,771
6 ComprehensiveNetIncome -21,825,771
7 BaseVar 42,156,326
8 EconomicCapitalRatiobeforeLimitedLiability 1.19
9 EconomicCapitalRatio 2.45

Edgar->Model Mapping

Feature Distribution

Change over Time